UnitedHealth Group Inc. Stock
€379.00
Your prediction
UnitedHealth Group Inc. Stock
Pros and Cons of UnitedHealth Group Inc. in the next few years
Pros
Cons
Performance of UnitedHealth Group Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | -0.990% | 2.793% | 9.685% | 58.575% | 36.617% | -15.960% | 8.920% |
| Humana Inc. | -1.690% | -0.559% | 14.103% | 85.998% | 62.113% | -13.319% | -8.928% |
| Centene Corp. | -0.240% | -3.867% | 8.299% | 139.884% | 66.826% | -8.517% | -5.443% |
| Cigna Corp. | 0.120% | -4.102% | 4.383% | 1.091% | 8.657% | -3.521% | 28.687% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.When evaluating the financials of UnitedHealth Group (UNH), it becomes apparent that this company stands as a formidable entity within the Healthcare Providers & Services industry. The metrics and trends presented in the financial statements, alongside the ratios provided, paint a picture of robust growth prospects, operational efficiency, and a sound balance sheet. However, not all appears pristine; there are nuances worth exploring that highlight both strengths and potential pitfalls.
Pros of UnitedHealth's Financials
Strong Revenue Streams: UnitedHealth has consistently shown impressive revenue growth, with total revenues amounting to approximately $385.44 billion over the last twelve months. The company's ability to generate significant top-line revenue is indicative of its market strength and wide-ranging service offerings.
Comments
News
UnitedHealth Stock: Is It Headed for $500?
UnitedHealth Group (NYSE: UNH) has been one of the hottest healthcare stocks over the past year, rising nearly 50%. The leading health insurer has been posting improved quarterly results, its
Is UnitedHealth Group a Buy After Its Latest Earnings Report?
UnitedHealth Group (NYSE: UNH) continued its strong 2026 performance on Thursday by delivering an outstanding second-quarter earnings report, with lower medical costs allowing profitability to soar
UnitedHealth Group Q2 Earnings Call Highlights
Key Points
- Interested in UnitedHealth Group Incorporated? Here are five stocks we like better.
- UnitedHealth beat Q2 expectations with adjusted EPS of $6.38 on $112 billion in revenue, and it
